Legal & General Group Plc

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 764068 London, X0

Position in TERN

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

+$0 QoQ

Shares Held

46,691

+158.6% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,870,015	$928,892,550
2	REGN	Regeneron Pharmaceuticals, Inc.	759,971	$473,872,316
3	ALNY	Alnylam Pharmaceuticals, Inc.	924,561	$278,320,596
4	RPRX	Royalty Pharma plc	3,800,504	$213,094,258
5	INCY	Incyte Corp	1,605,980	$182,053,892
6	ARGX	Argenx SE	177,164	$164,367,443
7	INSM	INSMED Inc	826,431	$88,114,072
8	RVMD	Revolution Medicines, Inc.	381,366	$71,422,223

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	46,691	+158.6%	Shares	Defined	2026-05-08
2025-12-31	—	18,058	+190.1%	Shares	Defined	2026-02-09
2025-09-30	—	6,224	-8.0%	Shares	Defined	2025-11-13
2025-06-30	—	6,765	+7.2%	Shares	Defined	2025-08-12
2025-03-31	—	6,311	0.0%	Shares	Defined	2025-05-15
2024-12-31	—	6,311	+24.3%	Shares	Defined	2025-02-13
2024-09-30	—	5,077	+0.5%	Shares	Defined	2025-02-28
2024-06-30	—	5,054	-81.6%	Shares	Defined	2025-05-29
2024-03-31	—	27,533	-0.3%	Shares	Defined	2025-05-29
2023-12-31	—	27,622	0.0%	Shares	Defined	2025-05-29
2023-09-30	—	27,622	+7.9%	Shares	Defined	2023-11-14
2023-06-30	—	25,601	+1660.7%	Shares	Defined	2023-08-14
2022-03-31	—	1,454	+13.7%	Shares	Defined	2022-05-16
2021-12-31	—	1,279	0.0%	Shares	Defined	2022-02-14
2021-09-30	—	1,279	+45.5%	Shares	Defined	2021-11-15
2021-06-30	—	879	0.0%	Shares	Defined	2021-08-12
2021-03-31	—	879	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.